Vigmed to invest in commercialization of a third unique

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Aug 27, 2013 at 9:00 AM

Vigmed to invest in commercialization of a third unique product group. The investment to be financed by a directed placement towards Bure Equity AB.

Vigmed have decided to force the development and commercialization of a third product category having received explicit requests from the market. For competitive reasons the company does not wish to specify what the product category is at present, but it is within Vigmed’s core area. Expectations for the new product are high and Vigmed expect to be first to market with a safe and effective solution in the specific application segment in 2015. To fund this effort, the Board intends to utilize a previously granted authorization from the Annual General Meeting and conduct a directed placement which will be made towards Bure Equity AB who will acquire shares in Vigmed Holding AB, corresponding to 9.5% of the total number of shares after the issue. In the agreement reached between the parties Bure buy newly issued shares at a price of 7 SEK per share with a "lock-up" period of 12 months. The transaction price has been determined by using the average market price for Vigmed’s share during the 30 days prior to August 19, 2013, the day on which the price per share was determined. Vigmed will receive almost 25 million SEK in new capital through this transaction. Vigmed has developed a number of unique and innovative products that have been met with great interest in the global healthcare market where there is an enormous need for safe products. In late autumn 2012 Vigmed obtained new capital of 53 million SEK through a private placement before listing on First North. This was deemed sufficient to build the business and to develop and introduce the first product families to the European market. The enterprise has largely followed the established plan and European market launches of safety solutions will be made for both I.V. catheter in 2013, and hypodermic needles in 2014. During meetings that have been held with future users of Vigmed’s products, it has transpired that a further product group, not available today and where the company can offer a unique solution, is strongly desired. For competitive reasons the company does not wish to make public the product group concerned. A prototype of the product has been developed and tested positively, but a significant capital injection is needed for large-scale production and market introduction. Due to the fact that there is significant potential in the market and that Vigmed can achieve first mover advantage if the company acts now, the Board has decided to exercise its authority and implement a rights issue to Bure Equti AB. The authorization of the Board of Vigmed Holding AB was resolved by the Annual General Meeting held on 1st February 2013, as set forth in the company presentation that was published in connection with the listing on First North earlier this year (see www.vigmed.com for details). Bure is a respected investment company with extensive knowledge of the medical technology industry. Vigmed’s point of view is that Bure can contribute positively and substantially to the company’s future development on several levels. It therefore seemed appropriate and beneficial for both parties to enter into this agreement as presented. Vigmed Holding’s chairman Lennart Holm commented that "it is hugely motivating for us to be able to further accelerate Vigmed’s expansion with the aid of this additional capital, and show that even a small company can sustain the drive towards a safer and more efficient healthcare environment. It is also a great opportunity for us that Bure has chosen to step in as a heavyweight shareholder. They have a vast knowledge not only in the financial sector, but also in medical technology, so we expect them to be a competent and active owner who helps build Vigmed to a rapidly growing and profitable company." For further information contact: Chairman of the Board Lennart Holm (+46 70-630 8562) or CEO Finn Ketler (+45 21 54 6408). Visit the company website at www.vigmed.com (http://file///C:/Users/mpj/Dropbox/Vigmed/IR%20aktiviteter/Press % 20releases/www.vigmed.com). Vigmed is a Swedish medical device company with the business goal of offering the market unique needlestick protected devices. Vigmed is headquartered in Helsingborg, Sweden, and has more than 10 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s home page: www.vigmed.com (http://file///C:/Users/mpj/Dropbox/Vigmed/IR%20aktiviteter/Press % 20releases/www.vigmed.com)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Merit Expands in New York with Bold Acquisition Move

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Duke Energy's Cost-Protection Plan Shields Ratepayers

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Ornellaia's 2026 Harvest: Adapting to Nature's Whims

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Wally Disrupts Dental Industry with $25M Funding

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Vitamin Angels Drives Global Nutrition Advancements

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Decoding CarBravo-Certified vs Traditional Used Cars

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

HelloNation Brings 'Edvertising' to NC REALTORS® Event

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

C3EL Expands Federal Footprint with Strategic Contracts

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....